PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
+4.56%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$9.45B
AUM Growth
+$9.45B
(+7.9%)
Cap. Flow
+$407M
Cap. Flow
% of AUM
4.31%
Top 10 Holdings %
Top 10 Hldgs %
22.94%
Holding
293
New
45
Increased
131
Reduced
62
Closed
40
Top Buys
| 1 |
Intel
INTC
|
$84.5M |
| 2 |
Arch Capital
ACGL
|
$77.1M |
| 3 |
HCA Healthcare
HCA
|
$66M |
| 4 |
Altria Group
MO
|
$58.7M |
| 5 |
Merck
MRK
|
$51.5M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$171M |
| 2 |
VR
Validus Hold Ltd
VR
|
$167M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$74.5M |
| 4 |
Nektar Therapeutics
NKTR
|
$60.8M |
| 5 |
UnitedHealth
UNH
|
$60.2M |
Sector Composition
| 1 | Technology | 24.19% |
| 2 | Financials | 23.76% |
| 3 | Healthcare | 20.17% |
| 4 | Communication Services | 10.96% |
| 5 | Industrials | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Chegg
CHGG
$159M
| $2.93M | 0.03% | +141,694 | New | +$2.93M |
|
|
DCPH
227
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.76M | 0.03% | 137,700 -112,300 | -45% | -$2.25M |
|
228
Analog Devices
ADI
$124B
| $2.52M | 0.03% | 27,688 +4,027 | +17% | +$367K |
|
229
HDFC Bank
HDB
$182B
| $2.5M | 0.03% | 25,354 +403 | +2% | +$39.8K |
|
230
Varonis Systems
VRNS
$6.61B
| $2.48M | 0.03% | 41,014 -35,500 | -46% | -$2.15M |
|
231
Adverum Biotechnologies
ADVM
$64.6M
| $2.32M | 0.02% | +400,000 | New | +$2.32M |
|
|
VRNA
232
Verona Pharma
VRNA
$9.16B
| $2M | 0.02% | 100,000 +4,851 | +5% | +$97K |
|
233
KVH Industries
KVHI
$110M
| $1.9M | 0.02% | 185,397 +2,900 | +2% | +$29.7K |
|
234
MongoDB
MDB
$25.7B
| $1.74M | 0.02% | 40,000 +20,000 | +100% | +$868K |
|
|
MTLS
235
Materialise
MTLS
$302M
| $1.64M | 0.02% | 141,662 | – | – |
|
|
AERI
236
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.63M | 0.02% | 30,000 -70,000 | -70% | -$3.8M |
|
|
CBAY
237
DELISTED
Cymabay Therapeutics
CBAY
| $1.3M | 0.01% | 100,000 -150,000 | -60% | -$1.95M |
|
|
DESP
238
DELISTED
Despegar.com
DESP
| $1.19M | 0.01% | 38,136 +16,136 | +73% | +$504K |
|
239
Goldman Sachs
GS
$226B
| $1M | 0.01% | +3,980 | New | +$1M |
|
240
Enterprise Financial Services Corp
EFSC
$2.27B
| $909K | 0.01% | 19,392 +1,149 | +6% | +$53.9K |
|
|
QD
241
Qudian
QD
$753M
| $653K | 0.01% | 55,832 +29,986 | +116% | +$351K |
|
242
Vipshop
VIPS
$8.25B
| $468K | ﹤0.01% | +28,188 | New | +$468K |
|
243
Esquire Financial Holdings
ESQ
$838M
| $435K | ﹤0.01% | +17,844 | New | +$435K |
|
|
AIFU
244
AIFU Inc. Class A Ordinary Share
AIFU
$67.5M
| $210K | ﹤0.01% | +7,754 | New | +$210K |
|
245
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – | -50,000 | Closed | -$1.51M |
|
246
Autodesk
ADSK
$67.3B
| – | – | -37,935 | Closed | -$3.98M |
|
247
AnaptysBio
ANAB
$569M
| – | – | -25,000 | Closed | -$2.52M |
|
248
AXIS Capital
AXS
$7.71B
| – | – | -300,000 | Closed | -$15.1M |
|
|
BLUE
249
DELISTED
bluebird bio
BLUE
| – | – | -17,500 | Closed | -$3.12M |
|
250
Boston Scientific
BSX
$156B
| – | – | -327,000 | Closed | -$8.11M |
|